Our screening for the differential expression of SUMO2 in liver cancer vs adjacent tissues using TCGA and GEO databases revealed that SUMO2 was highly expressed in the former and that the prognosis in patients with high SUMO2 expression was worse than that in patients with low SUMO2 expression. This evidence concerns the gene SUMO2 and liver cancer.